Now Diagnostics
In Brief This Week: Revvity, IntelliGenome, Angle, NowDiagnostics, Pramana
News items for the week of Jan. 20, 2025.
NowDx Countersues OraSure in Ongoing Legal Battle Over Point-of-Care Trade Secrets
Following OraSure's November 2024 lawsuit accusing NowDx of misappropriating trade secrets, NowDx has countersued OraSure over similar allegations.
Labcorp Inks Deal With NowDx to Become Distributor of OTC Syphilis Test
NowDx's First to Know Syphilis Test received FDA authorization in August, making it the first over-the-counter syphilis test to be authorized by the agency.
FDA Grants First Authorization for Over-the-Counter Syphilis Test
NowDiagnostics' at-home test detects antibodies against Treponema pallidum in 15 minutes from blood samples.
The company is seeking FDA de novo classification for the screening test, which is a capillary, blood-based lateral flow immunoassay.
Jul 9, 2024